We are live on ! Find out more
X

Xponance Portfolio holdings

AUM $16.3B
1-Year Est. Return 44.61%
This Fund
S&P 500
This Quarter Est. Return
+6.8%
1 Year Est. Return
+44.61%
3 Year Est. Return
+143.93%
5 Year Est. Return
+195.59%
10 Year Est. Return
+501.04%
AUM
$9.78B
AUM Growth
+$239M
Cap. Flow
-$199M
Cap. Flow %
-2.04%
Top 10 Hldgs %
39.84%
Holding
1,386
New
76
Increased
471
Reduced
763
Closed
70
Avg Time Held
12 quarters
Top 10 Avg Time Held
12 quarters
Top 20 Avg Time Held
10.4 quarters

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$24.4M
2
ORCL icon
Oracle
ORCL
+$10.8M
3
AMZN icon
Amazon
AMZN
+$10.3M
4
COST icon
Costco
COST
+$7.38M
5
XOM icon
ExxonMobil
XOM
+$6.78M

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$32.3M
2
ACN icon
Accenture
ACN
+$18.1M
3
ABBV icon
AbbVie
ABBV
+$14.4M
4
TMO icon
Thermo Fisher Scientific
TMO
+$13.3M
5
CAT icon
Caterpillar
CAT
+$10.7M

Sector Composition

Rank Sector Weight
1 Technology 37.1%
2 Consumer Discretionary 11.12%
3 Healthcare 10.76%
4 Financials 10.45%
5 Communication Services 10.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
IOVA icon
1226
Iovance Biotherapeutics
IOVA
$6.57B
$131K ﹤0.01%
16,279
+1,873
+13% +$20.1K
2023 Q2
4 quarters
DCH icon
1227
Dauch Corp
DCH
$1.31B
$127K ﹤0.01%
18,225
+2,800
+18% +$20.6K
2023 Q2
4 quarters
JBLU icon
1228
JetBlue
JBLU
$1.26B
$118K ﹤0.01%
19,424
-1,062
-5% -$6.4K
2020 Q2
16 quarters
ARDX icon
1229
Ardelyx
ARDX
$806M
$116K ﹤0.01%
15,609
+824
+6% +$5.79K
2023 Q2
4 quarters
DRH icon
1230
Diamondrock Hospitality Co
DRH
$2.69B
$112K ﹤0.01%
13,289
+568
+4% +$4.95K
2022 Q2
8 quarters
SAN icon
1231
Banco Santander
SAN
$196B
$112K ﹤0.01%
24,184
+4,532
+23% +$22.3K
2023 Q3
3 quarters
ADT icon
1232
ADT
ADT
$4.83B
$112K ﹤0.01%
14,716
+1,174
+9% +$8.13K
2023 Q2
4 quarters
HLMN icon
1233
Hillman Solutions
HLMN
$1.38B
$110K ﹤0.01%
12,375
+457
+4% +$4.31K
2023 Q2
4 quarters
MPT icon
1234
Medical Properties Trust
MPT
$1.87B
$110K ﹤0.01%
25,406
-3,210
-11% -$15.4K
2020 Q2
16 quarters
RKLB icon
1235
Rocket Lab Corp
RKLB
$41.1B
$106K ﹤0.01%
22,185
+4,997
+29% +$20.8K
2022 Q2
8 quarters
TDOC icon
1236
Teladoc Health
TDOC
$1.09B
$105K ﹤0.01%
+10,745
New +$131K
2024 Q2
0 quarters
CORZ icon
1237
Core Scientific
CORZ
$4.96B
$104K ﹤0.01%
+11,202
New +$57.2K
2024 Q2
0 quarters
DNB icon
1238
DELISTED
Dun & Bradstreet
DNB
$100K ﹤0.01%
+10,820
New +$104K
2024 Q2
0 quarters
PAYO icon
1239
Payoneer
PAYO
$2.42B
$99.3K ﹤0.01%
17,928
+1,942
+12% +$10.5K
2022 Q2
8 quarters
RXRX icon
1240
Recursion Pharmaceuticals
RXRX
$2.05B
$98.5K ﹤0.01%
+13,132
New +$115K
2024 Q2
0 quarters
NWL icon
1241
Newell Brands
NWL
$2.38B
$97.8K ﹤0.01%
15,263
+1,216
+9% +$9.05K
2020 Q2
16 quarters
MFG icon
1242
Mizuho Financial
MFG
$128B
$97.6K ﹤0.01%
23,063
+4,041
+21% +$16K
2023 Q3
3 quarters
BORR icon
1243
Borr Drilling
BORR
$1.48B
$97.1K ﹤0.01%
15,058
+1,767
+13% +$10.7K
2022 Q3
7 quarters
WIT icon
1244
Wipro
WIT
$17.8B
$96.8K ﹤0.01%
31,732
+5,664
+22% +$15.6K
2023 Q3
3 quarters
VIAV icon
1245
Viavi Solutions
VIAV
$10.2B
$96.3K ﹤0.01%
14,011
+515
+4% +$4K
2021 Q2
12 quarters
PLUG icon
1246
Plug Power
PLUG
$2.18B
$93.3K ﹤0.01%
40,035
+21,707
+118% +$62.2K
2021 Q2
12 quarters
GNL icon
1247
Global Net Lease
GNL
$1.77B
$93.2K ﹤0.01%
12,680
+956
+8% +$6.93K
2023 Q3
3 quarters
IONQ icon
1248
IonQ
IONQ
$14.1B
$88.1K ﹤0.01%
+12,532
New +$103K
2024 Q2
0 quarters
AMC icon
1249
AMC Entertainment Holdings
AMC
$2.73B
$88.1K ﹤0.01%
+17,683
New +$71K
2024 Q2
0 quarters
NMR icon
1250
Nomura Holdings
NMR
$28B
$87.9K ﹤0.01%
15,200
+2,615
+21% +$15.5K
2023 Q3
3 quarters

Similar funds

Xponance's Q2 2024 Portfolio in Review

As of Q2 2024, Xponance held 1,386 positions worth $9.78B, up 2.5% from $9.54B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Xponance's Q2 2024 filing shows 76 new, 471 increased, 763 reduced and 70 closed positions. Its largest new stake was GE Vernova: 36,466 shares worth $6.25M. The largest sale was UnitedHealth, an estimated $32.3M.

By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 34% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Xponance's largest Q2 2024 buy was GE Vernova: 36,466 shares worth $6.25M.
  • Xponance added most to Merck in Q2 2024, an estimated $24.4M increase.
  • Xponance's biggest Q2 2024 reduction was UnitedHealth, cutting an estimated $32.3M.
  • Xponance fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $8.15M.
  • Xponance's ten largest holdings make up 40% of its $9.78B portfolio in Q2 2024.
  • Xponance opened 76 new positions and closed 70 in Q2 2024.
  • Xponance's portfolio value rose 2.5% quarter-over-quarter to $9.78B.

Based on Xponance's 13F filing for Q2 2024, filed 14 Aug 2024.